BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36581836)

  • 1. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota.
    Cui MY; Cui ZY; Zhao MQ; Zhang MJ; Jiang QL; Wang JJ; Lu LG; Lu YY
    BMC Microbiol; 2022 Dec; 22(1):321. PubMed ID: 36581836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
    Chen J; Zhang Y; Min H; Zhi J; Ma S; Dong H; Yan J; Chi X; Zhang X; Yang Y
    Helicobacter; 2024; 29(2):e13077. PubMed ID: 38682268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
    Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
    Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic Changes of Gut Microbiota following Treatment of
    Dore MP; Sau R; Niolu C; Abbondio M; Tanca A; Bibbò S; Loria M; Pes GM; Uzzau S
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
    Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
    Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
    Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for
    Hu Y; Xu X; Ouyang YB; He C; Li NS; Xie C; Peng C; Zhu ZH; Shu X; Xie Y; Lu NH; Zhu Y
    Front Cell Infect Microbiol; 2022; 12():881968. PubMed ID: 35719338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota changes related to Helicobacter pylori eradication with vonoprazan containing triple therapy among adolescents: a prospective multicenter study.
    Kakiuchi T; Yamamoto K; Imamura I; Hashiguchi K; Kawakubo H; Yamaguchi D; Fujioka Y; Okuda M
    Sci Rep; 2021 Jan; 11(1):755. PubMed ID: 33436953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics modulate gastrointestinal microbiota after
    He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
    Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
    Zhou Y; Ye Z; Lu J; Miao S; Lu X; Sun H; Wu J; Wang Y; Huang Y
    Helicobacter; 2020 Oct; 25(5):e12721. PubMed ID: 32656891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies.
    Wang L; Yao H; Tong T; Lau K; Leung SY; Ho JWK; Leung WK
    Helicobacter; 2022 Apr; 27(2):e12871. PubMed ID: 34969161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial.
    Chen L; Xu W; Lee A; He J; Huang B; Zheng W; Su T; Lai S; Long Y; Chu H; Chen Y; Wang L; Wang K; Si J; Chen S
    EBioMedicine; 2018 Sep; 35():87-96. PubMed ID: 30145102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication.
    Hu Y; Xu X; Ouyang YB; He C; Li NS; Xie C; Peng C; Zhu ZH; Xie Y; Shu X; Lu NH; Zhu Y
    Helicobacter; 2022 Oct; 27(5):e12923. PubMed ID: 36036087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 years after a single eradication event.
    Gudra D; Pupola D; Skenders G; Leja M; Radovica-Spalvina I; Gorskis H; Vangravs R; Fridmanis D
    Helicobacter; 2020 Oct; 25(5):e12748. PubMed ID: 32776403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
    Martín-Núñez GM; Cornejo-Pareja I; Coin-Aragüez L; Roca-Rodríguez MDM; Muñoz-Garach A; Clemente-Postigo M; Cardona F; Moreno-Indias I; Tinahones FJ
    PLoS One; 2019; 14(3):e0213548. PubMed ID: 30870471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens for Helicobacter pylori eradication.
    Song ZQ; Zhou LY
    J Dig Dis; 2016 Apr; 17(4):260-7. PubMed ID: 26946480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Abe T; Sato S; Arita T
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):262-7. PubMed ID: 16460484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.
    Gotoda T; Takano C; Kusano C; Suzuki S; Ikehara H; Hayakawa S; Andoh A
    Helicobacter; 2018 Dec; 23(6):e12541. PubMed ID: 30311721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    Horii T; Suzuki S; Takano C; Shibuya H; Ichijima R; Kusano C; Ikehara H; Gotoda T
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3314-3321. PubMed ID: 34107551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.